Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 251–300 of 2,819 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06462014	Description of Relugolix Use in Patients With Prostate Cancer Within the VHA	completed	—	507	PfizerINDUSTRY	1	Dec 11, 2025	clinicaltrials
NCT05650021	Rectal Spacer for Prostate Cancer Radiation Image Guidance	completed	N/A	17	Milton S. Hershey Medical CenterOTHER	1	Dec 9, 2025	clinicaltrials
NCT06094322